Therapy News and Research

RSS

Usefulness of C-reactive protein test questioned

Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.

27 Feb 2007

Psychological depression contributes to worse medical outcomes for patients with heart failure

Heart failure, also known as congestive heart failure, is marked by the inability of the heart muscle to pump enough oxygen and nutrients in the blood to the body's tissues.

27 Feb 2007

Depression linked with a specific autoantibody and central nervous system dysfunction in lupus

Systemic lupus erythomatosus (SLE), often simply called lupus, is a complex autoimmune disease marked by joint pain, skin rashes, extreme fatigue, and depression, among other symptoms.

27 Feb 2007

Gene therapy shows promise as treatment for diseased lower limbs at risk for amputation

New research suggests that gene therapy is a safe treatment method to explore in patients whose lower limbs are at risk for amputation because of poor circulation caused by blocked blood vessels.

27 Feb 2007

Overly anxious and driven people susceptible to irritable bowel syndrome

The researchers studied 620 people who had confirmed gastroenteritis caused by a bacterial infection. None had had IBS before, or indeed any serious bowel disorder.

27 Feb 2007

High blood glucose levels may signal an increased risk for cancer in women

The March journal also includes a study that found a link between high levels of persistent organic pollutants (POPs) in a person's bloodstream and insulin resistance, a precursor for type 2 diabetes.

27 Feb 2007

DNA 'cages' to deliver drugs

By combining DNA macromolecules with polymers containing iron, molecular 'cages' can be made: porous structures capable of carrying and delivering drugs or DNA-fragments.

26 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

Short pieces of RNA, known as small interfering RNA (siRNA), have the potential to become a new class of anticancer drugs if researchers can solve the problem of how to deliver these fragile molecules to cancer cells.

26 Feb 2007

Quantum rods and dots image cancer cells

Brightly fluorescent quantum dots and quantum rods are quickly becoming important tools for identifying specific molecules and cells in living systems. Two new reports demonstrate some of the ways in which cancer researchers are using these nanoscale imaging agents.

26 Feb 2007

Perfluorocarbon nanoparticles track living cells

Stem cell therapy, primarily bone marrow transplantation, plays a key role in treating leukemia and other types of cancer.

26 Feb 2007

Genetically caused deafness may be reversible by compensating for a missing protein

Emory University researchers have found that in mice, increasing the amount of the protein connexin26 in the ear's cochlea compensates for an absence of another protein, connexin30.

26 Feb 2007

Androgen deprivation therapy may increase risk of death from heart disease in older men

Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

26 Feb 2007

Therapy News and Research

Usefulness of C-reactive protein test questioned

Psychological depression contributes to worse medical outcomes for patients with heart failure

Depression linked with a specific autoantibody and central nervous system dysfunction in lupus

Gene therapy shows promise as treatment for diseased lower limbs at risk for amputation

Overly anxious and driven people susceptible to irritable bowel syndrome

High blood glucose levels may signal an increased risk for cancer in women

DNA 'cages' to deliver drugs

Stimuvax investigational lung cancer vaccine phase III study starts

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

Quantum rods and dots image cancer cells

Perfluorocarbon nanoparticles track living cells

Genetically caused deafness may be reversible by compensating for a missing protein

Androgen deprivation therapy may increase risk of death from heart disease in older men

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Osteopenia and cancer in children and adolescents

Hormone patch could be safer than pills in relieving the symptoms of the menopause

Call for herpes simplex virus control measures for prevention of HIV transmission

Alternative, diet-based method of treating brain cancer

Clarient receives patent for "automated detection of objects in a biological sample"

Woman awarded millions in Prempro HRT breast cancer trial

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News